103 related articles for article (PubMed ID: 3655861)
1. Modification of Kiel and working formulation classifications for improved survival prediction in non-Hodgkin's lymphoma.
Nabholtz JM; Friedman S; Collin F; Guerrin J
J Clin Oncol; 1987 Oct; 5(10):1634-9. PubMed ID: 3655861
[TBL] [Abstract][Full Text] [Related]
2. Histologic subtypes and survival of Chinese patients with non-Hodgkin's lymphomas.
Liang R; Loke SL; Ho FC; Chiu E; Chan TK; Todd D
Cancer; 1990 Oct; 66(8):1850-5. PubMed ID: 2208041
[TBL] [Abstract][Full Text] [Related]
3. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
Nizze H; Bühring U
Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
[TBL] [Abstract][Full Text] [Related]
4. Primary non-Hodgkin's lymphomas of the female breast.
Giardini R; Piccolo C; Rilke F
Cancer; 1992 Feb; 69(3):725-35. PubMed ID: 1730123
[TBL] [Abstract][Full Text] [Related]
5. [Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma].
Glińska H; Papla B; Siuda M; Zulichowska J
Przegl Lek; 1989; 46(11):757-61. PubMed ID: 2623182
[TBL] [Abstract][Full Text] [Related]
6. Adult non-Hodgkin's lymphoma in Taiwan area: a clinicopathologic study of 123 cases based on working formulation classification.
Cheng AL; Chen YC; Su IJ; Wang CH; Hsieh HC; Chen CL; Lai HS; Liu TW; Tien HF; Shen MC
Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):108-13. PubMed ID: 2769210
[TBL] [Abstract][Full Text] [Related]
7. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.
Azab MB; Henry-Amar M; Rougier P; Bognel C; Theodore C; Carde P; Lasser P; Cosset JM; Caillou B; Droz JP
Cancer; 1989 Sep; 64(6):1208-17. PubMed ID: 2670184
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the histologic classification of peripheral T-cell lymphoma: a clinico-pathologic study of 71 HTLV-1 negative cases.
Remotti D; Pescarmona E; Burgio VL; Gastaldi R; Guglielmi C; Martelli M; Mandelli F; Baroni CD
Leuk Lymphoma; 1992 Nov; 8(4-5):371-9. PubMed ID: 1290962
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material.
Rabenhorst SH; Burini RC; Schmitt FC
Pathology; 1996 Jan; 28(1):12-6. PubMed ID: 8714262
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
[TBL] [Abstract][Full Text] [Related]
12. Relationship between prognostic factors and therapy in high-grade non-Hodgkin's lymphomas over two decades.
Federico M; Gobbi PG; Barbieri F; Silingardi V
Haematologica; 1989; 74(5):511-9. PubMed ID: 2511124
[TBL] [Abstract][Full Text] [Related]
13. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
14. Morphological and clinical significance of cell kinetics in non-Hodgkin's lymphomas.
Del Bino G; Silvestrini R; Costa A; Veneroni S; Giardini R
Basic Appl Histochem; 1986; 30(2):197-202. PubMed ID: 3741316
[TBL] [Abstract][Full Text] [Related]
15. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
[TBL] [Abstract][Full Text] [Related]
16. Morphological classification of non-Hodgkin malignant lymphoma. II. Comparison between Rappaport's classification and the Kiel classification.
Glimelius B; Hagberg H; Sundström C
Scand J Haematol; 1983 Jan; 30(1):13-24. PubMed ID: 6836219
[TBL] [Abstract][Full Text] [Related]
17. Multilobated non-Hodgkin's lymphoma. A clinicopathologic entity.
van Baarlen J; Schuurman HJ; van Unnik JA
Cancer; 1988 Apr; 61(7):1371-6. PubMed ID: 2449945
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
[TBL] [Abstract][Full Text] [Related]
20. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
Akerman M; Brandt L; Johnson A; Olsson H
Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
